Syra Health Corp. (NASDAQ:SYRA – Get Free Report) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 728,200 shares, a decline of 16.4% from the February 28th total of 870,700 shares. Currently, 7.5% of the shares of the company are sold short. Based on an average trading volume of 2,110,000 shares, the days-to-cover ratio is presently 0.3 days.
Syra Health Trading Down 11.5 %
SYRA opened at $0.25 on Tuesday. Syra Health has a twelve month low of $0.20 and a twelve month high of $2.27. The stock has a market cap of $2.84 million, a PE ratio of -0.40 and a beta of 3.20. The business’s 50 day moving average is $0.40 and its 200-day moving average is $0.41.
Syra Health (NASDAQ:SYRA – Get Free Report) last released its earnings results on Tuesday, March 11th. The company reported ($0.05) EPS for the quarter. Syra Health had a negative net margin of 54.90% and a negative return on equity of 131.94%. The company had revenue of $2.00 million for the quarter, compared to analyst estimates of $2.01 million. As a group, analysts forecast that Syra Health will post -0.53 EPS for the current year.
About Syra Health
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.
Featured Articles
- Five stocks we like better than Syra Health
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Berkshire Hathaway Gains Defy Stock Market Slump
- Consumer Discretionary Stocks Explained
- Palantir Stock Builds Momentum on New Partnership
- 3 Small Caps With Big Return Potential
- Tech Sell-Off Makes Microsoft Stock Look Like a Steal
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.